metyrapone has been researched along with Hepatitis, Chronic in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
KNICK, B | 1 |
BEHRENS, D | 1 |
ROTHER, F | 1 |
SACHSSE, W | 1 |
1 other study available for metyrapone and Hepatitis, Chronic
Article | Year |
---|---|
[METOPIRON THERAPY OF THE "ESCAPE PHENOMENON" AFTER PROLONGED CORTICOSTEROID THERAPY IN SUBACUTE AND CHRONIC HEPATITIS].
Topics: Adrenal Cortex Hormones; Hepatitis; Hepatitis A; Hepatitis, Chronic; Ketones; Metyrapone; Mineraloco | 1964 |